Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Outlook Therapeutics (OTLK) Gains from Sales and Divestitures: 2018-2019

Historic Gains from Sales and Divestitures for Outlook Therapeutics (OTLK) over the last 2 years, with Sep 2019 value amounting to $4,069.

  • Outlook Therapeutics' Gains from Sales and Divestitures was N/A to $109 in Q2 2020 from the same period last year, while for Jun 2020 it was $109, marking a year-over-year change of. This contributed to the annual value of $4,069 for FY2019, which is 96.14% down from last year.
  • Per Outlook Therapeutics' latest filing, its Gains from Sales and Divestitures stood at $4,069 for FY2019, which was down 96.14% from $105,361 recorded in FY2018.
  • In the past 5 years, Outlook Therapeutics' Gains from Sales and Divestitures registered a high of $105,361 during FY2018, and its lowest value of $4,069 during FY2019.
  • Its 2-year average for Gains from Sales and Divestitures is $54,715, with a median of $54,715 in 2018.
  • Data for Outlook Therapeutics' Gains from Sales and Divestitures shows a maximum YoY slumped of 96.14% (in 2019) over the last 5 years.
  • Outlook Therapeutics' Gains from Sales and Divestitures (Yearly) stood at $105,361 in 2018, then slumped by 96.14% to $4,069 in 2019.